A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors

NCT02243917 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
62
Enrollment
INDUSTRY
Sponsor class

Stopped MTD determined

Conditions

Interventions

Sponsor

Cleave Biosciences, Inc.